Authors: HARB GE MANDEMA JW DELAHUNTY T BENOWITZ NB COLEMAN R SHEINER LB JACOBSON MA

Citation: Ge. Harb et al., POPULATION PHARMACOKINETICS OF DIDANOSINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 173(1), 1996, pp. 273-273

Authors: HARB GE ALLDREDGE BK COLEMAN R JACOBSON MA

Citation: Ge. Harb et al., PHARMACOEPIDEMIOLOGY OF ADVERSE DRUG-REACTIONS IN HOSPITALIZED-PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE, Journal of acquired immune deficiency syndromes, 6(8), 1993, pp. 919-926

Authors: HARB GE JACOBSON MA

Citation: Ge. Harb et Ma. Jacobson, HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION - DOES IT INCREASE SUSCEPTIBILITY TO ADVERSE DRUG-REACTIONS, Drug safety, 9(1), 1993, pp. 1-8